Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diabetes diagnosis or severe lows may trigger PTSD, study finds

NCT ID NCT05662657

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study measured how common post-traumatic stress disorder (PTSD) is in adults with type 1 diabetes, focusing on PTSD related to the initial diabetes diagnosis or a severe hypoglycemic event. Researchers gave 297 participants questionnaires to check for PTSD symptoms. The goal was to understand the mental health burden tied to diabetes-related traumatic experiences.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds a high rate of PTSD, it could lead to better mental health screening and support for people with type 1 diabetes.
What could go wrong
This is a small, completed observational study using questionnaires, so it cannot prove cause and effect or apply to all diabetes patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

297 people

The number who actually took part.

Started

Nov 2022

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

population of insulin-treated type 1 diabetic patients

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older, * With type 1 diabetes, * Willing and able to complete all the questionnaires in French, * Who have given oral consent, * being affiliated to a social security scheme or being a beneficiary of such a scheme. Exclusion Criteria: * Non-diabetic type 1, * With an unstable psychiatric pathology, * Pregnant or breastfeeding women, * Subject to a measure for the protection of justice, * Having opposed the research.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier de Martigues

    Martigues, 13500, France

  • Hopital Saint Joseph

    Marseille, 13008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.